Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy-Reference-Cited by-同舟云学术

Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy

Published:1987-08 Issue:2 Volume:101 Page:171-181
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Muul Linda Mesler,Nason-Burchenal Kathryn,Carter Charles S.,Cullis Herbert,Slavin Dale,Hyatt Cornelia,Director Elaine P.,Leitman Susan F.,Klein Harvey G.,Rosenberg Steven A.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference9 articles.

1. Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin-2;Lafreniere;Cancer Res.,1985

2. Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins;Mazumder;Cancer Res.,1982

3. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2;Mule;Science,1984

4. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo;Mule;J. Immunol.,1985

5. Large scale production of human lymphokine activated killer cells for use in adoptive immunotherapy;Muul;J. Immunol. Methods,1986

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regional empowerment through decentralised governance under a centralised regulatory system facilitates the development of cellular therapy in China;The Lancet Haematology;2022-12

2. Prospective Evaluation of a Practical Guideline for Managing Positive Sterility Test Results in Cell Therapy Products;Biology of Blood and Marrow Transplantation;2019-01

3. Novel immunotherapies for the treatment of melanoma;Immunotherapy;2016-05

4. Enhancing Cancer Immunotherapy by Intracellular Delivery of Cell-Penetrating Peptides and Stimulation of Pattern-Recognition Receptor Signaling;Synthetic Vaccines;2012

5. Focus on Adoptive T Cell Transfer Trials in Melanoma;Clinical and Developmental Immunology;2010